Product Information
METFORMIN HCL 850 MG TABLET is a generic product labeled by ACI Healthcare USA, Inc., priced at $0.0248 per EA under NDC 71093013304. Its NADAC has been published 419 times since May 16, 2018.
FDA first approved this application on Sep 11, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
850 mg/1
Manufacturer
ACI Healthcare USA, Inc.NDC
71093013304
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
5/20/2026
Active Ingredients
METFORMIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA203769FDA Approved
9/11/2013
TE Code
AB
On Market Since
1/15/2018
Pharmacological Classes
Price Statistics
The NADAC for METFORMIN HCL 850 MG TABLET has been published 419 times since May 16, 2018, and over the history we have for it it has declined 13.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0248 per EA |
|---|---|
| All-time high | $0.0316 (Sep 11, 2019) |
| All-time low | $0.0196 (May 22, 2024) |
| 52-week high | $0.0248 |
| 52-week low | $0.0224 |
| Median price | $0.0278 |
| Average price | $0.0270 |
| Largest weekly change | +26.0% (Jun 19, 2024) |
| Weeks tracked | 419 |
| Tracking since | May 16, 2018 |
1W
N/A
1M
N/A
3M
N/A
6M
+2.0%
1Y
+8.9%
3Y
-12.4%
5Y
-12.0%
All
-13.1%
Last surveyed May 20, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of METFORMIN HCL 850 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METFORMIN HCL 850 MG TABLET, manufactured by ACI Healthcare USA, Inc., is $0.0248 per EA (NDC 71093013304), effective May 20, 2026.
How has the price of METFORMIN HCL 850 MG TABLET changed over time?
Over the history we have for it, the NADAC for METFORMIN HCL 850 MG TABLET has declined 13.1%. It has been tracked across 419 weekly CMS publications since May 16, 2018.
What are the highest and lowest recorded NADAC prices for METFORMIN HCL 850 MG TABLET?
Since May 16, 2018, the NADAC for METFORMIN HCL 850 MG TABLET has ranged from a low of $0.0196 (May 22, 2024) to a high of $0.0316 (Sep 11, 2019), with a median of $0.0278 per EA.
Are there cheaper alternatives to METFORMIN HCL 850 MG TABLET?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METFORMIN HCL 850 MG TABLET, is $0.0239 per EA — about 4% below METFORMIN HCL 850 MG TABLET.
Who manufactures METFORMIN HCL 850 MG TABLET?
METFORMIN HCL 850 MG TABLET (NDC 71093013304) is labeled by ACI Healthcare USA, Inc., and CMS classifies it as a generic product.